Clinical Trial Update: Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study [Phase 4]

View source ↗

Summary

Phase 4 MEMPSOLAR trial evaluating residual disease memory in psoriasis skin during EnstiLAR therapy and narrow-band UVB treatment; the study is active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Psoriasis Vulgaris

Drugs mentioned

• Enstilar (calcipotriene; betamethasone dipropionate)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Psoriasis Vulgaris, Psoriasis | Phase 4 | Status: ACTIVE_NOT_RECRUITING